BIOMAT Database Logo BIOMAT Database Logo

[Clinico-bacteriological evaluation of the effectiveness of amikacin in chronic bronchopulmonary diseases and mucoviscidosis in children]. 1987

I K Volkov, and L K Katosova, and L Z Skala, and G D Sotnikova, and A G Nekhorosheva

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D001988 Bronchiolitis Inflammation of the BRONCHIOLES. Bronchiolitides
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

I K Volkov, and L K Katosova, and L Z Skala, and G D Sotnikova, and A G Nekhorosheva
[Effectiveness of therapeutic and rehabilitation complexes in the treatment of children with chronic bronchopulmonary diseases and mucoviscidosis].
January 1988, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
I K Volkov, and L K Katosova, and L Z Skala, and G D Sotnikova, and A G Nekhorosheva
[Clinico-bacteriological evaluation of the effectiveness of erythromycin in chronic diffuse strepto-staphyloderma].
August 1962, Vestnik dermatologii i venerologii,
I K Volkov, and L K Katosova, and L Z Skala, and G D Sotnikova, and A G Nekhorosheva
[Clinical and bacteriological evaluation of minocycline in mucoviscidosis in children].
January 1974, Le Poumon et le coeur,
I K Volkov, and L K Katosova, and L Z Skala, and G D Sotnikova, and A G Nekhorosheva
[Clinico-bacteriological evaluation of the effectiveness of piperacillin in suppurative-inflammatory diseases of the lungs and pleura].
June 1992, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
I K Volkov, and L K Katosova, and L Z Skala, and G D Sotnikova, and A G Nekhorosheva
[Clinical and bacteriological efficacy and tolerability of meropenem in the treatment of bronchopulmonary affections in children with mucoviscidosis].
January 2006, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
I K Volkov, and L K Katosova, and L Z Skala, and G D Sotnikova, and A G Nekhorosheva
Bacteriological study in children with mucoviscidosis.
September 1954, Maandschrift voor kindergeneeskunde,
I K Volkov, and L K Katosova, and L Z Skala, and G D Sotnikova, and A G Nekhorosheva
[POSSIBILITIES OF CORRELATION BETWEEN CYSTIC FIBROSIS OF THE PANCREAS (MUCOVISCIDOSIS) AND CHRONIC BRONCHOPULMONARY DISEASES].
August 1963, Giornale di clinica medica,
I K Volkov, and L K Katosova, and L Z Skala, and G D Sotnikova, and A G Nekhorosheva
[Etiology of acute and chronic bronchopulmonary diseases in children. I. The results of a bacteriological and immunological study].
November 1983, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
I K Volkov, and L K Katosova, and L Z Skala, and G D Sotnikova, and A G Nekhorosheva
[Clinico-epidemiological study of chronic bronchopulmonary diseases in rural inhabitants].
January 1984, Sovetskoe zdravookhranenie,
I K Volkov, and L K Katosova, and L Z Skala, and G D Sotnikova, and A G Nekhorosheva
[Clinical and bacteriological study on the use of carbenicillin in the bronchopulmonary infections of mucoviscidosis].
October 1971, Minerva pediatrica,
Copied contents to your clipboard!